Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-06-01
著者
-
Murakami Masaaki
Laboratory Of Developmental Immunology And Crest Program Of Japan Science And Technology Agency Grad
-
Hirano Toshio
Laboratory Of Developmental Immunology And Crest Program Of Japan Science And Technology Agency Grad
-
Hirano Toshio
Laboratory Of Developmental Immunology Graduate School Of Frontier Biosciences And Graduate School O
-
JIN Gui-Hua
Laboratory of Developmental Immunology, Graduate School of Frontier Biosciences and Graduate School
-
Jin Gui-hua
Laboratory Of Developmental Immunology Graduate School Of Frontier Biosciences And Graduate School O
-
Murakami Masaaki
Laboratory Of Developmental Immunology Graduate School Of Frontier Biosciences And Graduate School O
関連論文
- IFN-γ expression in CD8^+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4^+ T Cell death
- Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir
- IL-6-gp130-STAT3 in T cells directs the development of IL-17+ T_h with a minimum effect on that of Treg in the steady state
- The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis
- CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8^+ T cells in a manner dependent on IL-4
- Zinc suppresses T_h17 development via inhibition of STAT3 activation
- IL-6 positively regulates Foxp3^+CD8^+ T cells in vivo
- Intracellular zinc homeostasis and zinc signaling
- Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation